-
King, Acura seek regulatory approval for Acurox
BRISTOL, Tenn. — Drug makers King Pharmaceuticals and Acura Pharmaceuticals have submitted a regulatory approval application to the Food and Drug Administration for an opioid pain reliever.
The two drug makers announced Tuesday the submission for Acurox (oxycodone hydrochloride), an immediate-release tablet for relief of moderate to severe pain.
The tablets use Acura’s aversion technology, designed to deter abuse of the drug by dissolving or crushing the pills.
-
FDA approves Safyral
WAYNE, N.J. — The Food and Drug Administration has approved a new oral contraceptive developed by Bayer.
Safyral is a combination of Yasmin, also developed by Bayer, with 451 mcg levomefolate calcium, which is a B vitamin known as a folate. It is the second oral contraceptive from Bayer that features folate.